Results 11 to 20 of about 2,761,482 (311)

Hierarchical ResNeXt Models for Breast Cancer Histology Image Classification [PDF]

open access: yesImage Analysis and Recognition. ICIAR 2018. LNCS, vol 10882. Springer, Cham, 2018
Microscopic histology image analysis is a cornerstone in early detection of breast cancer. However these images are very large and manual analysis is error prone and very time consuming. Thus automating this process is in high demand. We proposed a hierarchical system of convolutional neural networks (CNN) that classifies automatically patches of these
D Berry   +6 more
arxiv   +3 more sources

The shifting nature of women’s experiences and perceptions of ductal carcinoma in situ [PDF]

open access: yes, 2011
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to one year later.
Baum   +51 more
core   +1 more source

Unique case of inverted papilloma of septum with nasopharyngeal carcinoma:Is it a metachronous tumour? [PDF]

open access: yes, 2020
Inverted papilloma is a rare and benign tumour. It affects the nasal cavity and paranasal sinuses, has a high rate of recurrence and is associated with malignant transformation.
Ferguson, Aaron S. J.   +4 more
core   +3 more sources

Programmed death ligand 1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma [PDF]

open access: yesAsia Pac J Clin Oncol 2020 1 9, 2020
Aim: To determine the programmed death ligand-1 (PD-L1) expression rates in sarcomatoid lung carcinomas and to compare clinicopathologic features and survival rates of PD-L1-positive and negative patients. Methods: PD-L1 expression was evaluated in 65 surgically resected sarcomatoid carcinomas.
arxiv   +1 more source

Contralateral prophylactic mastectomies. Correlations between primary tumor and histological findings of controlateral breast [PDF]

open access: yes, 2016
Backgound: In Italy in 2015 48,000 new cases of breast carcinomas were diagnosed. Women who are diagnosed with breast cancer have a significant risk of developing contralateral breast cancer during the rest of their lives and this risk is closely ...
Amanti, Claudio   +10 more
core   +1 more source

Deep Learning-Based Grading of Ductal Carcinoma In Situ in Breast Histopathology Images [PDF]

open access: yesLaboratory Investigation. Published February 19th, 2021, 2020
Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer that can progress into invasive ductal carcinoma (IDC). Studies suggest DCIS is often overtreated since a considerable part of DCIS lesions may never progress into IDC. Lower grade lesions have a lower progression speed and risk, possibly allowing treatment de-escalation.
arxiv   +1 more source

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast [PDF]

open access: yes, 2013
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ductal carcinoma in situ of the breast. METHODS: One hundred and twenty-one cases of high-grade ductal carcinoma in situ, pure or associated with ...
Balabram, Débora   +4 more
core   +4 more sources

Renal papillary carcinoma developed in a kidney transplant recipient with late IgA-nephropathy [PDF]

open access: yes, 2016
With improvements in immunosuppressive therapy, patient and graft survival in renal transplant recipients have been prolonged. Increasing donor age and patient survival rates have been related to an increase in the number of de novo tumors ...
BERLOCO, Pasquale Bartolomeo   +7 more
core   +1 more source

A Case Report: Lobular Carcinoma In Situ in a Male Patient with Subsequent Invasive Ductal Carcinoma Identified on Screening Breast MRI [PDF]

open access: yes, 2012
Lobular carcinoma in situ is a form of in situ neoplasia that develops within the terminal lobules of the breast. It is an extremely rare finding in males due to the lack of lobular development in the male breast.
Bulkin, Yekaterina   +4 more
core   +4 more sources

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma. [PDF]

open access: yes, 2018
Fibrolamellar carcinoma has a distinctive morphology and immunophenotype, including cytokeratin 7 and CD68 co-expression. Despite the distinct findings, accurate diagnosis of fibrolamellar carcinoma continues to be a challenge.
Alves, Venancio Af   +27 more
core   +1 more source

Home - About - Disclaimer - Privacy